Merck & Co Inc (LSE:0QAH)
$ 100 0 (0%) Market Cap: 252.20 Bil Enterprise Value: 275.80 Bil PE Ratio: 20.90 PB Ratio: 5.67 GF Score: 87/100

Merck & Co Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 09, 2021 / 06:50PM GMT
Release Date Price: $72.42 (-0.27%)
Carter Lewis Gould
Barclays Bank PLC, Research Division - Senior Analyst

Okay. Great. We are live. Good afternoon and welcome to the Barclays Global Healthcare Conference. Next up, we are pleased to welcome Merck to a fireside chat today. Joining us from the company is Michael Nally, Chief Marketing Officer, and Peter Dannenbaum is also joining from the IR team. Michael, Peter, thank you very much for the time today.

Michael T. Nally
Merck & Co., Inc. - CMO & Executive VP

Thank you, Carter.

Peter Dannenbaum
Merck & Co., Inc. - VP of IR

Thanks, Carter.

Michael T. Nally
Merck & Co., Inc. - CMO & Executive VP

Great to be here.

Questions & Answers

Carter Lewis Gould
Barclays Bank PLC, Research Division - Senior Analyst

Right. So I'm looking forward to the conversation. Before we touch on all the individual product opportunities that everybody wants to hear about, I want to ask a few kind of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot